ReviewFuture oncology (London, England)2024

Immune checkpoint inhibitor use in head and neck squamous cell carcinoma: the current landscape and future perspectives.

Elinor R Gatfield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.